Yenasys Unveils AI Innovations at Tech in Asia 2024 by VRITIMES July 27, 2024 Yenasys Unveils AI Innovations at Tech in Asia 2024Kuala Lumpur, July 25, 2024 – Yenasys, a leader in Omni Channel ...
InfoComm India 2024 -The Largest Edition of the Pro AV Exhibition to Date – Returns 3-5 September at Jio World Convention Centre (JWCC) Mumbai, India by CISION PRNewswire July 27, 2024 MUMBAI, India, July 26, 2024 /PRNewswire/ -- InfoComm India, India's foremost professional audiovisual (Pro AV) exhibition, is set to return ...
Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024 by CISION PRNewswire July 27, 2024 SINGAPORE, July 27, 2024 /PRNewswire/ -- Chenghe Acquisition II Co. (the "Company") today announced that, commencing on July 29, 2024, ...
Disruptive Doctors Presents: The Healthcare Revolution Conference and Exhibition 2024 – Empowering Doctors to Impact Healthcare Differently by VRITIMES July 27, 2024 Kuala Lumpur, Malaysia – June 2024 – Disruptive Doctors is excited to announce the Healthcare Revolution Conference and Exhibition, scheduled ...
Mega Matrix announced that FlexTV App achieved the new milestone, surging into Top 8 on the Apple Store Entertainment Chart (Free Apps, Japan) as of July 26, 2024 by CISION PRNewswire July 26, 2024 PALO ALTO, Calif., July 27, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced ...
vivo Unveils Future Imaging Trends and Announces Winners of VISION+ Mobile PhotoAwards 2024 by CISION PRNewswire July 26, 2024 XINING, China, July 27, 2024 /PRNewswire/ -- vivo today held the 2024 vivo Imaging Conference in Xining, China, where it showcased ...
BingX Launches Pre-Market Trading for Early Access to New Digital Assets by CISION PRNewswire July 26, 2024 VILNIUS, Lithuania, July 27, 2024 /PRNewswire/ -- BingX, a leading cryptocurrency exchange, proudly announces the launch of BingX Pre-Market Trading feature. ...
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation by CISION PRNewswire July 26, 2024 The positive CHMP opinion is based on results from the Phase II PHAROS trial, which demonstrated an objective response rate (ORR) ...